Yuen, Man-Fung
Chen, Ding-Shinn
Dusheiko, Geoffrey M.
Janssen, Harry L. A.
Lau, Daryl T. Y.
Locarnini, Stephen A.
Peters, Marion G.
Lai, Ching-Lung
Article History
First Online: 7 June 2018
Competing interests
: M.-F.Y. has received research grants and/or served as an adviser for AbbVie, Arrowhead Pharmaceuticals, Biocartis, BristolMyers Squibb, Fujirebio, Gilead Sciences, GlaxoSmithKline, LF Asia Limited, Merck Sharp & Dohme, Novartis Pharmaceuticals, Roche Molecular Systems and Sysmex Corporation. D.S.C. has served as an adviser for Bristol-Myers Squibb and Merck Sharp & Dohme. G.M.D. has received research grants and/or served as an adviser for Abbott Laboratories, AbbVie, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck Sharp & Dohme and Transgene. H.L.A.J. has received grants and/or served as consultant for AbbVie, Arbutus, Bristol-Myers Squibb, Gilead Sciences, Janssen, Medimmune, Merck and Roche Molecular Systems. D.T.Y.L. has received research grants from Bristol-Myers Squibb, Gilead Sciences and Roche Molecular Systems and has served as consultant for AbbVie and Gilead Sciences. S.A.L. has served as an adviser and received consulting fees from Arrowhead Pharmaceuticals, AusBio Ltd., Gilead Sciences, Roche Molecular Systems and Janssen and has contract research grants with Arrowhead Pharmaceuticals, Gilead Sciences and Spring Bank Pharmaceuticals, Inc. M.G.P.'s spouse is employed at Hoffman-La Roche. C.-L.L. has received speaker fees from Bristol-Myers Squibb, Gilead Sciences and Novartis and is an advisory board member of Gilead Sciences.